Maximilian F. Konig is an Assistant Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. He received his medical degree from Charité – Universitätsmedizin Berlin and Humboldt-Universität zu Berlin. Dr. Konig completed residency training in Internal Medicine in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School, and fellowship training in Clinical and Molecular Rheumatology at Johns Hopkins Hospital. In addition, he received postdoctoral research training in the Division of Rheumatology and the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins. Dr. Konig’s research interests include immuno-engineering and elucidating mechanisms underlying the initiation and progression of autoimmune diseases. His lab works to develop novel precision cellular and protein-based immunotherapies for the treatment of autoimmune and rheumatic diseases, aiming to selectively eliminate autoreactive immune cells while preserving protective immune responses. Such therapies have the potential to effectively treat and prevent autoimmune disease without increasing the risk of infection, a primary cause of death in patients treated with current immunosuppressive drugs. His lab employs similar engineering approaches to develop more potent cellular therapies for hard-to-treat cancers.